NCT00752128

RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,349 (actual)
• Sponsor: Medtronic Vascular · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of the RESOLUTE international registry is to document the safety and overall clinical performance of the Resolute Zotarolimus-Eluting Coronary Stent System in a 'real-world' patient population requiring stent implantation.

Detailed description

As part of the broader clinical program of the Resolute stent, the RESOLUTE International registry will expand the experience and understanding of the device performance in a 'real-world' setting. The registry intends to enroll patients from a large number of centers under commercial usage conditions, with the aim to reflect 'real-world' usage as much as possible.

Conditions

• Coronary Artery Disease
• Cardiovascular Diseases

Interventions

Type	Name	Description
DEVICE	Endeavor Resolute Zotarolimus-Eluting Coronary Stent System	Stent implantation

Timeline

• Start date: 2008-08-01
• Primary completion: 2010-10-01
• Completion: 2012-12-01
• First posted: 2008-09-15
• Last updated: 2013-04-25
• Results posted: 2011-12-06

Locations

1 site across 1 country: Germany